Carbon monoxide poisoning

When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 23 Jun 2024
Last updated: 22 Apr 2024

Summary

Definition

History and exam

Key diagnostic factors

  • risk of carbon monoxide exposure
  • headache
  • nausea
  • vomiting
  • vertigo
  • altered consciousness
  • weakness
  • dizziness
  • dyspnoea
  • pain
  • hypotension or hypertension
  • sleep changes
  • irritability
  • flu-like symptoms
Full details

Other diagnostic factors

  • delayed neuropsychiatric features
  • other severe neurological symptoms
  • focal neurological abnormalities
  • cardiac arrest
  • pulmonary oedema
  • disseminated intravascular coagulation
  • skin lesions
Full details

Risk factors

  • exposure to incomplete combustion of carbon-containing material
  • exposure to methylene chloride
Full details

Diagnostic investigations

1st investigations to order

  • blood gas analysis
  • 12-lead ECG
  • cardiac monitoring
  • glucose
  • full blood count
  • urea and electrolytes
  • creatinine
  • troponin
  • creatine kinase
Full details

Investigations to consider

  • CT head
  • magnetic resonance spectroscopy
  • chest x-ray
  • liver function tests
  • pregnancy test
Full details

Treatment algorithm

ACUTE

all patients (acute or chronic carbon monoxide poisoning)

Contributors

Expert advisers

Alexander Alexiou, MB, BS, BSc, DCH, FRCEM, Dip IMC RCSEd

Emergency Medicine Consultant

Barts Health NHS Trust

Physician Response Unit Consultant

London’s Air Ambulance

Royal London Hospital

London

UK

Disclosures

AA declares that he has no competing interests.

Acknowledgements

BMJ Best Practice would like to gratefully acknowledge the previous team of expert contributors, whose work is retained in parts of the content:

Jason J Rose, MD, MBA

Assistant Professor of Medicine and Biomedical Engineering

University of Pittsburgh

Pittsburgh

PA

Disclosures: JJR is a co-inventor on patent applications for the use of heme-based molecules as antidotes for CO poisoning. JJR is a shareholder, officer, and director of Globin Solutions, Inc. Globin Solutions, Inc. has an exclusive license to this technology. Globin Solutions, Inc. had an option agreement to technology directed at using hydroxycobalamin for CO poisoning from Virginia Commonwealth University in the last 12 months. JJR is an author of publications cited within this topic.

Peer reviewers

Robert Taylor, MBChB, MRCP(UK), MRCP(London), DipMedTox, DipTher PGDME, FHEA FRCEM

Acute Hospital Sub Dean (Cornwall)

Honorary Clinical Senior Lecturer

Consultant Emergency Physician

University of Exeter Medical School

Royal Cornwall Hospitals NHS trust

Truro

UK

Disclosures

RT declares that he has no competing interests.

Editors

Emma Quigley

Section Editor, BMJ Best Practice

Disclosures

EQ declares that she has no competing interests.

Tannaz Aliabadi-Oglesby

Lead Section Editor, BMJ Best Practice

Disclosures

TAO declares that she has no competing interests.

Julie Costello

Comorbidities Editor, BMJ Best Practice

Disclosures

JC declares that she has no competing interests.

Adam Mitchell

Drug Editor, BMJ Best Practice

Disclosures

AM declares that he has no competing interests.

  • Differentials

    • Viral infection
    • Alcohol intoxication
    • Migraine
    More Differentials
  • Guidelines

    • Guideline for oxygen use in healthcare and emergency settings
    • Carbon monoxide poisoning: recognise the symptoms and tackle the cause
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer